Coloplast says industry should take fresh look at pricing
Coloplast’s research department will have to advance a greater number of inventions from its pipeline in coming years. Meanwhile, the medtech group considers pricing in a whole new way and says the rest of the industry would do well to follow its lead.
by Leonora Beck
Coloplast must have done something right in terms of pricing of its ostomy pouches and catheters. The group’s profit margin has gone from 12% to 32% in a matter of five years and the aim is to hike that up to 39% over the next five years.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
